Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles

Brain Pathology

Volumn 25, Issue 2, 2015, Pages 202-208

  Koelsche, Christian ^a,b   Hovestadt, Volker ^b   Jones, David T W ^b   Capper, David ^a,b   Sturm, Dominik ^a,b   Sahm, Felix ^a,b   Schrimpf, Daniel ^a   Adeberg, Sebastian ^a   Böhmer, Katja ^a   Hagenlocher, Christian ^b   Mechtersheimer, Gunhild ^a   Kohlhof, Patricia ^c   Mühleisen, Helmut ^d   Beschorner, Rudi ^e   Hartmann, Christian ^f   Braczynski, Anne Kristin ^g   Mittelbronn, Michel ^b,g   Buslei, Rolf ^h   Becker, Albert ⁱ   Grote, Alexander ⁱ   Urbach, Horst ^j   Staszewski, Ori ^j   Prinz, Marco ^j,k   Hewer, Ekkehard ^l   Pfister, Stefan M ^a,b   Von Deimling, Andreas ^a,b   Reuss, David E ^a,b   more..

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c Stuttgart Hospital   (Germany)

^d Hospital Ludwigsburg   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g GOETHE UNIVERSITY   (Germany)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁱ UNIVERSITY HOSPITAL BONN   (Germany)

^j UNIVERSITY OF FREIBURG   (Germany)

^k UNIVERSITY OF FREIBURG   (Germany)

^l UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

450k; copy number variants; GNA11; GNAQ; melanocytoma; melanoma; melanotic schwannoma; TERT promoter

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 17P; CHROMOSOME 21; CHROMOSOME 22Q; CHROMOSOME 6Q; CHROMOSOME 9; CHROMOSOME LOSS; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; GENE MUTATION; HUMAN; KARYOTYPE; MELANOCYTOSIS; MELANOMA; MELANOTIC SCHWANNOMA; MONOSOMY; NERVOUS SYSTEM TUMOR; NEURILEMOMA; ADOLESCENT; ADULT; AGED; BRAIN TUMOR; CHILD; CHROMOSOME ABERRATION; CLASSIFICATION; FEMALE; GENETIC EPIGENESIS; GENETICS; INFANT; MALE; MIDDLE AGED; MUTATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHROMOSOME ABERRATIONS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; INFANT; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEURILEMMOMA; YOUNG ADULT;

EID: 84922716104     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12228     Document Type: Article

References (39)

1. Bertola DR, Pereira AC, Brasil AC, Suzuki L, Leite C, Falzoni R, et al (2012) Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship? Clin Genet 81: 595-597.
2. Brat DJ, Giannini C, Scheithauer BW, Burger PC, (1999) Primary melanocytic neoplasms of the central nervous systems. Am J Surg Pathol 23: 745-754.
3. Bydon A, Gutierrez JA, Mahmood A, (2003) Meningeal melanocytoma: an aggressive course for a benign tumor. J Neurooncol 64: 259-263.
4. Carney JA, (1990) Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol 14: 206-222.
5. Egberts F, Bergner I, Kruger S, Haag J, Behrens HM, Hauschild A, Rocken C, (2014) Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas. Ann Oncol 25: 246-250.
6. Egberts F, Kruger S, Behrens HM, Bergner I, Papaspyrou G, Werner JA, et al (2014) Melanomas of unknown primary frequently harbor TERT-promoter mutations. Melanoma Res 24: 131-136.
7. Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, et al (2014) Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry. Cancer Cell 25: 831-845.
8. Gessi M, Hammes J, Lauriola L, Dorner E, Kirfel J, Kristiansen G, et al (2013) GNA11 and N-RAS mutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system. Neuropathol Appl Neurobiol 39: 417-425.
9. Gessi M, van de Nes J, Griewank K, Barresi V, Buckland ME, Kirfel J, et al (2014) Absence of TERT promoter mutations in primary melanocytic tumors of the central nervous system. Neuropathol Appl Neurobiol 40: 794-797.
10. Goldgeier MH, Klein LE, Klein-Angerer S, Moellmann G, Nordlund JJ, (1984) The distribution of melanocytes in the leptomeninges of the human brain. J Invest Dermatol 82: 235-238.
11. Harbour JW, (2012) The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res 25: 171-181.
12. Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, et al (2013) TERT promoter mutations in familial and sporadic melanoma. Science 339: 959-961.
13. Hovestadt V, Remke M, Kool M, Pietsch T, Northcott PA, Fischer R, et al (2013) Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol 125: 913-916.
14. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA, (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339: 957-959.
15. Kim OH, Kim SJ, Choo HJ, Lee SJ, Lee IS, Kim JY, Kim H, (2013) Spinal meningeal melanocytoma with benign histology showing leptomeningeal spread: case report. Korean J Radiol 14: 470-476.
16. Kusters-Vandevelde HV, van Engen-van Grunsven IA, Kusters B, van Dijk MR, Groenen PJ, Wesseling P, Blokx WA, (2010) Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis. Acta Neuropathol 120: 755-764.
17. Kusters-Vandevelde HV, Klaasen A, Kusters B, Groenen PJ, van Engen-van Grunsven IA, van Dijk MR, et al (2010) Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system. Acta Neuropathol 119: 317-323.
18. Liubinas SV, Maartens N, Drummond KJ, (2010) Primary melanocytic neoplasms of the central nervous system. J Clin Neurosci 17: 1227-1232.
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
20. Mensink HW, Kilic E, Vaarwater J, Douben H, Paridaens D, de Klein A, (2008) Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet 181: 108-111.
21. Mudhar HS, Doherty R, Salawu A, Sisley K, Rennie IG, (2013) Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations. Br J Ophthalmol 97: 924-928.
22. Muller A, Holzmann K, Kestler HA, (2007) Visualization of genomic aberrations using Affymetrix SNP arrays. Bioinformatics 23: 496-497.
23. Murali R, Wiesner T, Rosenblum MK, Bastian BC, (2012) GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol 123: 457-459.
24. Navas M, Pascual JM, Fraga J, Pedrosa M, Shakur S, Carrasco R, et al (2009) Intracranial intermediate-grade meningeal melanocytoma with increased cellular proliferative index: an illustrative case associated with a nevus of Ota. J Neurooncol 95: 105-115.
25. Quatresooz P, Pierard-Franchimont C, Pierard GE, (2008) Highlighting the immunohistochemical profile of melanocytomas: review. Oncol Rep 19: 1367-1372.
26. Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, et al (2008) Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro-Oncol 10: 199-207.
27. Serrano C, Simonetti S, Hernandez-Losa J, Valverde C, Carrato C, Bague S, et al (2013) BRAF V600E and KRAS G12S mutations in peripheral nerve sheath tumours. Histopathology 62: 499-504.
28. Shiota K, Kogo Y, Ohgane J, Imamura T, Urano A, Nishino K, et al (2002) Epigenetic marks by DNA methylation specific to stem, germ and somatic cells in mice. Genes Cells 7: 961-969.
29. Smith AB, Rushing EJ, Smirniotopoulos JG, (2009) Pigmented lesions of the central nervous system: radiologic-pathologic correlation. Radiographics 29: 1503-1524.
30. Solus JF, Kraft S, (2013) Ras, Raf, and MAP kinase in melanoma. Adv Anat Pathol 20: 217-226.
31. Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22: 425-437.
32. Torres-Mora J, Dry S, Li X, Binder S, Amin M, Folpe AL, (2014) Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma". Am J Surg Pathol 38: 94-105.
33. Vallat-Decouvelaere AV, Wassef M, Lot G, Catala M, Moussalam M, Caruel N, Mikol J, (1999) Spinal melanotic schwannoma: a tumour with poor prognosis. Histopathology 35: 558-566.
34. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, et al (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457: 599-602.
35. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, et al (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363: 2191-2199.
36. Wadasadawala T, Trivedi S, Gupta T, Epari S, Jalali R, (2010) The diagnostic dilemma of primary central nervous system melanoma. J Clin Neurosci 17: 1014-1017.
37. Wang F, Qiao G, Lou X, Song X, Chen W, (2011) Malignant transformation of intracranial meningeal melanocytoma. Case report and review of the literature. Neuropathology 31: 414-420.
38. Wang H, Zhang S, Wu C, Zhang Z, Qin T, (2013) Melanocytomas of the central nervous system: a clinicopathological and molecular study. Eur J Clin Invest 43: 809-815.
39. Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, et al (2014) Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 25: 822-830.